Predictors of the persistence of conduct difficulties in children with cognitive delay.
Eric Emerson, Stewart Einfeld, Roger J Stancliffe
https://pubmed.ncbi.nlm.nih.gov/21501168/Actively Recruiting
Led by De Viersprong · Updated on 2026-04-13
470
Participants Needed
4
Research Sites
N/A
Total Duration
Researchers are evaluating a special type of multisystemic therapy called MST-ID for adolescents aged 10 to 19 with severe behavioural problems living in families affected by intellectual disability ID. The study compares MST-ID to standard multisystemic therapy MST to see if MST-ID is better at reducing rule-breaking and other behavioural issues. The study uses both numbers-based assessments and families personal experiences to understand treatment effects and is sponsored by De Viersprong. The treatments involved are intensive, home-based therapies with 3 to 5 home visits each week over about three to five months. Both MST and MST-ID target adolescents behavioural problems by involving their family, school, and social environments. MST-ID differs by adapting its approach to the needs of families with ID, using simpler language, more structured sessions, and extra practice time to help families apply what they learn. Families receive either standard MST or the MST-ID specialization following usual referrals. Participants complete questionnaires at five time points start of treatment, end of treatment, and three follow-ups at 6, 12, and 18 months after treatment. Data collection includes standard MST monitoring and special interviews or discussions to capture families experiences. Researchers measure rule-breaking behaviour, other behavioural problems, parenting stress, out-of-home placements, school or work status, addictions, social networks, parenting skills, family relations, social support, and adolescent success with peers and education or work. The study lasts over 18 months with ongoing assessments to track impact.
CONDITIONS
Effectiveness of Multisystemic Therapy for Adolescents From Families With Intellectual Disabilities
A
Annemarieke Blankestein, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
De Viersprong
Lead Sponsor
Stichting tot Steun
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 to 5 months
Participants receive Multisystemic Therapy (MST) or Multisystemic Therapy tailored for intellectual disabilities (MST-ID), which are intensive, home-based treatments involving 3-5 home visits per week. Treatment focuses on addressing severe behavioural problems of adolescents by working with the adolescent and family across multiple life domains, using structured sessions with accessible language and visual supports for families with intellectual disabilities.
3 to 5 home visits per week
Duration - Up to 18 months after treatment completion
Participants are monitored for outcomes such as behavioural improvements, parenting stress, school or work participation, and family social support for up to 18 months after treatment ends.
Multiple follow-up assessments over 18 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Eric Emerson, Stewart Einfeld, Roger J Stancliffe
https://pubmed.ncbi.nlm.nih.gov/21501168/Annemarieke Blankestein, Rachel van der Rijken, Hester V Eeren...
https://pubmed.ncbi.nlm.nih.gov/30620111/Annemarieke Blankestein, Aurelie Lange, Rachel van der Rijken...
https://pubmed.ncbi.nlm.nih.gov/31883357/De Viersprong
Lead Sponsor
Stichting tot Steun
Collaborating Sponsor